Literature DB >> 12648223

Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations.

Gabriele Richard1, Nkecha Brown, Fatima Rouan, Jan-Gerrit Van der Schroeff, Emilia Bijlsma, Lawrence F Eichenfield, Virginia P Sybert, Kenneth E Greer, Peter Hogan, Carmen Campanelli, John G Compton, Sherri J Bale, John J DiGiovanna, Jouni Uitto.   

Abstract

Erythrokeratodermia variabilis is an autosomal dominant genodermatosis characterized by persistent plaque-like or generalized hyperkeratosis and transient red patches of variable size, shape, and location. The disorder maps to a cluster of connexin genes on chromosome 1p34-p35.1 and, in a subset of families, results from mutations in the gene GJB3 encoding the gap junction protein connexin-31 (Cx31). A recent report suggested the involvement of another connexin gene (GJB4) in the etiology of erythrokeratodermia variabilis. In this study, we sequenced the coding region of GJB4 in 13 unrelated erythrokeratodermia variabilis families without detectable mutations in GJB3. Mutation analysis revealed six distinct missense mutations in five families and a sporadic case of erythrokeratodermia variabilis, all of which were not found in controls. Mutation G12D, identified in an extended Dutch family, lies in the predicted amino-terminus and may interfere with the flexibility of this domain, connexin selectivity, or gating polarity of gap junction channels. Other mutations (R22H, T85P, F137L, F189Y) were located in the transmembrane domains of Cx30.3, and are predicted to hinder regulation of voltage gating or alter the kinetics of channel closure. Affected individuals of two unrelated families harbored point mutations leading to amino acid substitution F137L, which was also reported in GJB3, yet the extent and severity of hyperkeratosis was milder compared to the corresponding mutation in GJB3. Two mutations (T85P, F137L) were associated with the occurrence of rapidly changing erythematous patches with prominent, circinate, or gyrate borders in affected children but not in adults, supporting the notion that this feature is specific to Cx30.3 defects. Nevertheless, we observed highly variable intrafamilial phenotypes, suggesting the strong influence of modifying genetic and epigenetic factors. In addition to pathogenic mutations, we identified several missense mutations and a 4 bp deletion within the GJB4 coding region, which might represent either inconsequential polymorphisms or recessive mutations. In conclusion, our results demonstrate genetic heterogeneity in erythrokeratodermia variabilis, and emphasize that intercellular communication mediated by both Cx31 and Cx30.3 is crucial for epidermal differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648223     DOI: 10.1046/j.1523-1747.2003.12080.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  [Progressive symmetric erythrokeratodermia of Darier-Gottron].

Authors:  H Ott; S Lehmann; P Poblete-Gutiérrez; J Frank
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

2.  N-terminal residues in Cx43 and Cx40 determine physiological properties of gap junction channels, but do not influence heteromeric assembly with each other or with Cx26.

Authors:  Joanna Gemel; Xianming Lin; Richard D Veenstra; Eric C Beyer
Journal:  J Cell Sci       Date:  2006-06-01       Impact factor: 5.285

Review 3.  Life cycle of connexins in health and disease.

Authors:  Dale W Laird
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

Review 4.  Gap junctions in inherited human disease.

Authors:  Georg Zoidl; Rolf Dermietzel
Journal:  Pflugers Arch       Date:  2010-02-07       Impact factor: 3.657

5.  Systemic retinoids in the management of ichthyoses and related skin types.

Authors:  John J Digiovanna; Theodora Mauro; Leonard M Milstone; Matthias Schmuth; Jorge R Toro
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

6.  Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia.

Authors:  Sabine Duchatelet; Alain Hovnanian
Journal:  J Invest Dermatol       Date:  2015-06       Impact factor: 8.551

Review 7.  Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.

Authors:  Himadri Patel; Pritish Nilendu; Devashree Jahagirdar; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cancer Biol Ther       Date:  2017-12-08       Impact factor: 4.742

8.  An intact connexin N-terminus is required for function but not gap junction formation.

Authors:  John W Kyle; Peter J Minogue; Bettina C Thomas; Denise A Lopez Domowicz; Viviana M Berthoud; Dorothy A Hanck; Eric C Beyer
Journal:  J Cell Sci       Date:  2008-07-29       Impact factor: 5.285

9.  Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct.

Authors:  Meejin Ahn; Jonathan Lee; Andreas Gustafsson; Alan Enriquez; Eric Lancaster; Jai-Yoon Sul; Philip G Haydon; David L Paul; Yan Huang; Charles K Abrams; Steven S Scherer
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

Review 10.  Connexin channels in congenital skin disorders.

Authors:  Evelyn Lilly; Caterina Sellitto; Leonard M Milstone; Thomas W White
Journal:  Semin Cell Dev Biol       Date:  2016-01-13       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.